Literature DB >> 22179059

Atrial remodeling in atrial fibrillation and some related microRNAs.

Deepak Sharma1, Guangping Li, Gang Xu, Yuzhi Liu, Yanmin Xu.   

Abstract

Atrial fibrillation is the most common sustained arrhythmia associated with substantial cardiovascular morbidity and mortality, with stroke being the most critical complication. The role of atrial remodeling has emerged as the new pathophysiological mechanism of atrial fibrillation. Electrical remodeling and structural remodeling will increase the probability of generating multiple atrial wavelets by enabling rapid atrial activation and dispersion of refractoriness. MicroRNAs (miRNAs) are small non-coding RNAs of 20-25 nucleotides in length that regulate expression of target genes through sequence-specific hybridization to the 3' untranslated region of messenger RNAs and either block translation or direct degradation of their target messenger RNA. They have also been implicated in a variety of pathological conditions, such as arrhythmogenesis and atrial fibrillation. Target genes of miRNAs have the potential to affect atrial fibrillation vulnerability.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179059     DOI: 10.1159/000334434

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

1.  Effect of selective IK,ACh inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation.

Authors:  Merle Friederike Fenner; Helena Carstensen; Sarah Dalgas Nissen; Eva Melis Hesselkilde; Christine Scott Lunddahl; Maja Adler Hess Jensen; Ameli Victoria Loft-Andersen; Stefan Michael Sattler; Pyotr Platonov; Said El-Haou; Claire Jackson; Raymond Tang; Robert Kirby; John Ford; Ulrich Schotten; James Milnes; Ulrik Svane Sørensen; Thomas Jespersen; Rikke Buhl
Journal:  Br J Pharmacol       Date:  2020-06-24       Impact factor: 8.739

2.  Helicobacter pylori infection in Chinese patients with atrial fibrillation.

Authors:  De-Zhao Wang; Wei Chen; Song Yang; Jun Wang; Qun Li; Qiang Fu; Shi-Jing Li; Bu-Xing Chen
Journal:  Clin Interv Aging       Date:  2015-04-28       Impact factor: 4.458

Review 3.  microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.

Authors:  Claudio de Lucia; Klara Komici; Giulia Borghetti; Grazia Daniela Femminella; Leonardo Bencivenga; Alessandro Cannavo; Graziamaria Corbi; Nicola Ferrara; Steven R Houser; Walter J Koch; Giuseppe Rengo
Journal:  Front Med (Lausanne)       Date:  2017-06-12

Review 4.  RNAs and Gene Expression Predicting Postoperative Atrial Fibrillation in Cardiac Surgery Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Muhammad Shuja Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Derek James Dosdall
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

5.  Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis.

Authors:  Hai Liu; Guang-Xian Chen; Meng-ya Liang; Han Qin; Jian Rong; Jian-ping Yao; Zhong-kai Wu
Journal:  BMC Cardiovasc Disord       Date:  2014-01-25       Impact factor: 2.298

6.  Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation.

Authors:  Hai Liu; Han Qin; Guang-xian Chen; Meng-ya Liang; Jian Rong; Jian-ping Yao; Zhong-kai Wu
Journal:  J Transl Med       Date:  2014-04-06       Impact factor: 5.531

7.  Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation.

Authors:  Leanne Harling; Jonathan Lambert; Hutan Ashrafian; Ara Darzi; Nigel J Gooderham; Thanos Athanasiou
Journal:  Eur J Cardiothorac Surg       Date:  2016-07-15       Impact factor: 4.191

8.  Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.

Authors:  Rosa Doñate Puertas; Audrey Jalabert; Emmanuelle Meugnier; Vanessa Euthine; Philippe Chevalier; Sophie Rome
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.